174 related articles for article (PubMed ID: 36417955)
1. Rationale and design for the myocardial ischemia and transfusion (MINT) randomized clinical trial.
Carson JL; Brooks MM; Chaitman BR; Alexander JH; Goodman SG; Bertolet M; Abbott JD; Cooper HA; Rao SV; Triulzi DJ; Fergusson DA; Kostis WJ; Noveck H; Simon T; Steg PG; DeFilippis AP; Goldsweig AM; Lopes RD; White H; Alsweiler C; Morton E; Hébert PC;
Am Heart J; 2023 Mar; 257():120-129. PubMed ID: 36417955
[TBL] [Abstract][Full Text] [Related]
2. Transfusion thresholds for guiding red blood cell transfusion.
Carson JL; Stanworth SJ; Dennis JA; Trivella M; Roubinian N; Fergusson DA; Triulzi D; Dorée C; Hébert PC
Cochrane Database Syst Rev; 2021 Dec; 12(12):CD002042. PubMed ID: 34932836
[TBL] [Abstract][Full Text] [Related]
3. Effect of a Restrictive vs Liberal Blood Transfusion Strategy on Major Cardiovascular Events Among Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Clinical Trial.
Ducrocq G; Gonzalez-Juanatey JR; Puymirat E; Lemesle G; Cachanado M; Durand-Zaleski I; Arnaiz JA; Martínez-Sellés M; Silvain J; Ariza-Solé A; Ferrari E; Calvo G; Danchin N; Avendaño-Solá C; Frenkiel J; Rousseau A; Vicaut E; Simon T; Steg PG;
JAMA; 2021 Feb; 325(6):552-560. PubMed ID: 33560322
[TBL] [Abstract][Full Text] [Related]
4. Benefits and harms of red blood cell transfusions in patients with septic shock in the intensive care unit.
Holst LB
Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836806
[TBL] [Abstract][Full Text] [Related]
5. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion.
Carson JL; Stanworth SJ; Roubinian N; Fergusson DA; Triulzi D; Doree C; Hebert PC
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD002042. PubMed ID: 27731885
[TBL] [Abstract][Full Text] [Related]
6. Restrictive vs liberal red blood cell transfusion strategies in patients with acute myocardial infarction and anemia: Rationale and design of the REALITY trial.
Ducrocq G; Calvo G; González-Juanatey JR; Durand-Zaleski I; Avendano-Sola C; Puymirat E; Lemesle G; Arnaiz JA; Martínez-Sellés M; Rousseau A; Cachanado M; Vicaut E; Silvain J; Karam C; Danchin N; Simon T; Steg PG;
Clin Cardiol; 2021 Feb; 44(2):143-150. PubMed ID: 33405291
[TBL] [Abstract][Full Text] [Related]
7. Liberal transfusion strategy to prevent mortality and anaemia-associated, ischaemic events in elderly non-cardiac surgical patients - the study design of the LIBERAL-Trial.
Meybohm P; Lindau S; Treskatsch S; Francis R; Spies C; Velten M; Wittmann M; Gueresir E; Stoppe C; Kowark A; Coburn M; Selleng S; Baschin M; Jenichen G; Meersch M; Ermert T; Zarbock A; Kranke P; Kredel M; Helf A; Laufenberg-Feldmann R; Ferner M; Wittenmeier E; Gürtler KH; Kienbaum P; de Abreu MG; Sander M; Bauer M; Seyfried T; Gruenewald M; Choorapoikayil S; Mueller MM; Seifried E; Brosteanu O; Bogatsch H; Hasenclever D; Zacharowski K;
Trials; 2019 Feb; 20(1):101. PubMed ID: 30717805
[TBL] [Abstract][Full Text] [Related]
8. Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia.
Carson JL; Brooks MM; Hébert PC; Goodman SG; Bertolet M; Glynn SA; Chaitman BR; Simon T; Lopes RD; Goldsweig AM; DeFilippis AP; Abbott JD; Potter BJ; Carrier FM; Rao SV; Cooper HA; Ghafghazi S; Fergusson DA; Kostis WJ; Noveck H; Kim S; Tessalee M; Ducrocq G; de Barros E Silva PGM; Triulzi DJ; Alsweiler C; Menegus MA; Neary JD; Uhl L; Strom JB; Fordyce CB; Ferrari E; Silvain J; Wood FO; Daneault B; Polonsky TS; Senaratne M; Puymirat E; Bouleti C; Lattuca B; White HD; Kelsey SF; Steg PG; Alexander JH;
N Engl J Med; 2023 Dec; 389(26):2446-2456. PubMed ID: 37952133
[TBL] [Abstract][Full Text] [Related]
9. Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support.
Estcourt LJ; Malouf R; Trivella M; Fergusson DA; Hopewell S; Murphy MF
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD011305. PubMed ID: 28128441
[TBL] [Abstract][Full Text] [Related]
10. Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease.
Carson JL; Brooks MM; Abbott JD; Chaitman B; Kelsey SF; Triulzi DJ; Srinivas V; Menegus MA; Marroquin OC; Rao SV; Noveck H; Passano E; Hardison RM; Smitherman T; Vagaonescu T; Wimmer NJ; Williams DO
Am Heart J; 2013 Jun; 165(6):964-971.e1. PubMed ID: 23708168
[TBL] [Abstract][Full Text] [Related]
11. A multicentre randomised controlled trial of Transfusion Indication Threshold Reduction on transfusion rates, morbidity and health-care resource use following cardiac surgery (TITRe2).
Reeves BC; Pike K; Rogers CA; Brierley RC; Stokes EA; Wordsworth S; Nash RL; Miles A; Mumford AD; Cohen A; Angelini GD; Murphy GJ
Health Technol Assess; 2016 Aug; 20(60):1-260. PubMed ID: 27527344
[TBL] [Abstract][Full Text] [Related]
12. Clinical Practice Guidelines From the AABB: Red Blood Cell Transfusion Thresholds and Storage.
Carson JL; Guyatt G; Heddle NM; Grossman BJ; Cohn CS; Fung MK; Gernsheimer T; Holcomb JB; Kaplan LJ; Katz LM; Peterson N; Ramsey G; Rao SV; Roback JD; Shander A; Tobian AA
JAMA; 2016 Nov; 316(19):2025-2035. PubMed ID: 27732721
[TBL] [Abstract][Full Text] [Related]
13. Postoperative red blood cell transfusion strategy in frail anemic elderly with hip fracture. A randomized controlled trial.
Gregersen M
Dan Med J; 2016 Apr; 63(4):. PubMed ID: 27034188
[TBL] [Abstract][Full Text] [Related]
14. Liberal versus conservative transfusion strategy for patients with acute myocardial infarction and anemia: A systematic review and meta-analysis.
Sukhon F; Jabri A; Al-Abdouh A; Alameh A; Alhuneafat L; Jebaje ZA; Khader S; Mhanna M; Koenig G; Alaswad K; Villablanca P; AlQarqaz M
Curr Probl Cardiol; 2024 Feb; 49(2):102247. PubMed ID: 38040217
[TBL] [Abstract][Full Text] [Related]
15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
16. Six-Month Outcomes after Restrictive or Liberal Transfusion for Cardiac Surgery.
Mazer CD; Whitlock RP; Fergusson DA; Belley-Cote E; Connolly K; Khanykin B; Gregory AJ; de Médicis É; Carrier FM; McGuinness S; Young PJ; Byrne K; Villar JC; Royse A; Grocott HP; Seeberger MD; Mehta C; Lellouche F; Hare GMT; Painter TW; Fremes S; Syed S; Bagshaw SM; Hwang NC; Royse C; Hall J; Dai D; Mistry N; Thorpe K; Verma S; Jüni P; Shehata N;
N Engl J Med; 2018 Sep; 379(13):1224-1233. PubMed ID: 30146969
[TBL] [Abstract][Full Text] [Related]
17. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial.
Hajjar LA; Vincent JL; Galas FR; Nakamura RE; Silva CM; Santos MH; Fukushima J; Kalil Filho R; Sierra DB; Lopes NH; Mauad T; Roquim AC; Sundin MR; Leão WC; Almeida JP; Pomerantzeff PM; Dallan LO; Jatene FB; Stolf NA; Auler JO
JAMA; 2010 Oct; 304(14):1559-67. PubMed ID: 20940381
[TBL] [Abstract][Full Text] [Related]
18. Transfusion trigger after operations in high cardiac risk patients (TOP) trial protocol. Protocol for a multicenter randomized controlled transfusion strategy trial.
Kougias P; Mi Z; Zhan M; Carson JL; Dosluoglu H; Nelson P; Sarosi GA; Arya S; Norman LE; Sharath S; Scrymgeour A; Ollison J; Calais LA; Biswas K
Contemp Clin Trials; 2023 Mar; 126():107095. PubMed ID: 36690072
[TBL] [Abstract][Full Text] [Related]
19. The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction.
Chaitman BR; Hardison RM; Adler D; Gebhart S; Grogan M; Ocampo S; Sopko G; Ramires JA; Schneider D; Frye RL;
Circulation; 2009 Dec; 120(25):2529-40. PubMed ID: 19920001
[TBL] [Abstract][Full Text] [Related]
20. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design.
; Maron DJ; Hochman JS; O'Brien SM; Reynolds HR; Boden WE; Stone GW; Bangalore S; Spertus JA; Mark DB; Alexander KP; Shaw L; Berger JS; Ferguson TB; Williams DO; Harrington RA; Rosenberg Y
Am Heart J; 2018 Jul; 201():124-135. PubMed ID: 29778671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
